Skip to main content

S. 657

Referred to Committee

A bill to amend title XXVII of the Public Health Service Act to establish requirements with respect to prescription drug benefits.

Introduced 3/5/2019•116th Congress•Senate

Latest Action

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

3/5/2019 • Senate

Summary

This bill prohibits health insurers and contracted entities that provide pharmacy benefits management services from receiving a price reduction or other remuneration from prescription drug manufacturers. The prohibition does not apply if (1) the price reduction is reflected at the point-of-sale; and (2) the other remuneration is a transparent, flat service fee that the manufacturer pays in relation to pharmacy benefits management services.

Introduced in Senate • 3/5/2019

Enter your district to see how this bill affects your community
-

Topics & Subjects

Policy Area: Health
Health care costs and insuranceInflation and pricesPrescription drugs

Congressional Votes (0)

No recorded votes yet

Roll call votes will appear here as the bill moves through Congress

Related Federal Spending

Sponsor & Cosponsors (2)

Party Breakdown

0
Democrats
2
Republicans
0
Independents

Sponsor

S[
Sen. Braun, Mike [R-IN]

Republican • IN

Sponsored 3/5/2019

Cosponsors (1)

S[
Sen. Blackburn, Marsha [R-TN]

R-TN

Joined 3/13/2019

Bill Journey

Originated in the Senate

Introduced

March 5, 2019

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Committee Review

Floor Debate

Passed Chamber

Other Chamber

President

Enacted into Law

Text Versions (1)

Introduced in Senate3/5/2019

Details

Bill TypeS
Current StatusReferred to Committee
Cosponsors1